Peru: Sinopharm COVID-19 vaccine's efficacy is 79.34% | News | ANDINA
Photo: ANDINA/Juan Carlos Guzmán Negrini 09:30 | Lima, Mar. 6. The Ministry of Health (Minsa) on Saturday affirmed that the Sinopharm COVID-19 vaccine reached an effectiveness of 79.34% in phase III of clinical trials in the United Arab Emirates (UAE), according to the Beijing Institute of Biological Products. Minsa made this clarification after Ernesto Bustamante said in a local TV program that Sinopharm vaccine's Wuhan strain had only 33% effectiveness, while the Beijing strain vaccine had 11.5%. In a statement, Minsa affirmed that —in addition to the reports of ...